2013
DOI: 10.5114/fn.2013.34197
|View full text |Cite
|
Sign up to set email alerts
|

Original article Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis: effect of corticosteroid therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
27
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(28 citation statements)
references
References 27 publications
1
27
0
Order By: Relevance
“…Most patients finally suffer from a smouldering, chronic inflammatory, progressive MS process in the long term. Concomitantly, an upregulated free-radical synthesis may occur in the central nervous system [Ljubisavljevic et al 2013;Mitosek-Szewczyk et al 2010] that may be influenced by steroids [Seven et al 2013]. Free radicals play a role in a variety of normal regulatory systems.…”
Section: Introductionmentioning
confidence: 99%
“…Most patients finally suffer from a smouldering, chronic inflammatory, progressive MS process in the long term. Concomitantly, an upregulated free-radical synthesis may occur in the central nervous system [Ljubisavljevic et al 2013;Mitosek-Szewczyk et al 2010] that may be influenced by steroids [Seven et al 2013]. Free radicals play a role in a variety of normal regulatory systems.…”
Section: Introductionmentioning
confidence: 99%
“…A single study also reported significantly higher 3-NT in an SPMS group compared to RRMS [81]. Conversely, Seven et al [27] reported reduced 3-NT immediately following relapse and following corticosteroid treatment (p<0.001). Case mix differences may partly explain this discrepancy as the latter is the only study in this section in which all MS subjects had RRMS and were enrolled after an acute relapse.…”
Section: Protein Nitrosylationmentioning
confidence: 88%
“…Three studies described no significant difference but were heterogeneous as to the MS disease phenotype, and none considered patients following an acute relapse [24][25][26]. A single study [27] found the opposite: significantly lower mean tNOx in RRMS patients compared to control groups; no significant study characteristics were identified to explain this disparity. tNOx has been considered across RRMS and SPMS groups with mixed resultsone study reported significantly higher mean tNOx in RRMS than SPMS [22] whereas others reported no significant difference [16,17,23].…”
Section: Peripheral Bloodmentioning
confidence: 89%
“…Systemic methylprednisolone administration has been shown to induce rat lens opacity (19) . The protective effect of methylprednisolone against oxidative injury has been found in several disease types (20)(21)(22)(23)(24) . However, no studies in the literature have related the impact of systemic methylprednisolone to the oxidative stress of crystalline lenses.…”
Section: Discussionmentioning
confidence: 99%